WallStreetZenWallStreetZen

NASDAQ: TCON
Tracon Pharmaceuticals Inc Stock Forecast, Predictions & Price Target

OverviewForecast
EarningsDividendOwnership

Analyst price target for TCON

Based on 1 analyst offering 12 month price targets for Tracon Pharmaceuticals Inc.
Min Forecast
$60.00+3,251.96%
Avg Forecast
$60.00+3,251.96%
Max Forecast
$60.00+3,251.96%

Should I buy or sell TCON stock?

Based on 1 analyst offering ratings for Tracon Pharmaceuticals Inc.
Buy
Strong Buy
0 analysts 0%
Buy
1 analysts 100%
Hold
0 analysts 0%
Sell
0 analysts 0%
Strong Sell
0 analysts 0%

Be the first to know when Wall Street analysts revise their TCON stock forecasts and price targets.

TCON stock forecasts by analyst

Analyst / FirmRatingActionPrice TargetUpside/DownsideDateAnalyst Color
lockedlocked$00.00+00.00%2024-04-03

1 of 1

Forecast return on equity

Is TCON forecast to generate an efficient return?
Insufficient data to display

Forecast return on assets

Is TCON forecast to generate an efficient return on assets?
Company
N/A
Industry
N/A

TCON revenue forecast

What is TCON's revenue in the next 3 years based on estimates from 1 analyst?
Avg 1 year Forecast
$9.0M-25.28%
Avg 2 year Forecast
$17.6M+46.45%
Avg 3 year Forecast
$44.1M+266.13%
TCON's revenue is forecast to... subscribe to Premium to read more.
Forecast High Revenue Growth Forecast

TCON revenue growth forecast

How is TCON forecast to perform vs Biotechnology companies and vs the US market?
Company
50.59%
Industry
37.04%
Market
9.92%
TCON's revenues are forecast to... subscribe to Premium to read more.
Forecast Revenue Growth vs Industry Forecast
TCON's revenues are forecast to... subscribe to Premium to read more.
Forecast Revenue Growth vs Market Forecast

TCON vs Biotech Stocks

TickerPricePrice TargetUp/downsideConsensus
TCON$1.79$60.00+3,251.96%Buy
GNPX$2.12$10.00+371.70%Buy
ENSC$0.55N/AN/A
LGVN$1.67$60.00+3,492.81%Buy
CING$0.84$8.00+852.38%Buy
View Top Biotech Stocks

Tracon Pharmaceuticals Stock Forecast FAQ

Is Tracon Pharmaceuticals Stock a good buy in 2024, according to Wall Street analysts?

The consensus among 1 Wall Street analyst covering (NASDAQ: TCON) stock is to Buy TCON stock.

Out of 1 analyst, 0 (0%) are recommending TCON as a Strong Buy, 1 (100%) are recommending TCON as a Buy, 0 (0%) are recommending TCON as a Hold, 0 (0%) are recommending TCON as a Sell, and 0 (0%) are recommending TCON as a Strong Sell.

If you're new to stock investing, here's how to buy Tracon Pharmaceuticals stock.

What is TCON's revenue growth forecast for 2024-2026?

(NASDAQ: TCON) Tracon Pharmaceuticals's forecast annual revenue growth rate of 50.59% is forecast to beat the US Biotechnology industry's average forecast revenue growth rate of 37.04%, and it is also forecast to beat the US market's average forecast revenue growth rate of 9.92%.

Tracon Pharmaceuticals's revenue in 2024 is $12,045,000.On average, 1 Wall Street analysts forecast TCON's revenue for 2024 to be $20,477,025, with the lowest TCON revenue forecast at $20,477,025, and the highest TCON revenue forecast at $20,477,025. On average, 1 Wall Street analysts forecast TCON's revenue for 2025 to be $40,134,969, with the lowest TCON revenue forecast at $40,134,969, and the highest TCON revenue forecast at $40,134,969.

In 2026, TCON is forecast to generate $100,337,423 in revenue, with the lowest revenue forecast at $100,337,423 and the highest revenue forecast at $100,337,423.

What is TCON's forecast return on assets (ROA) for 2024-2027?

(NASDAQ: TCON) forecast ROA is N/A, which is lower than the forecast US Biotechnology industry average of N/A.

What is TCON's Price Target?

According to 1 Wall Street analyst that have issued a 1 year TCON price target, the average TCON price target is $60.00, with the highest TCON stock price forecast at $60.00 and the lowest TCON stock price forecast at $60.00.

The Wall Street analyst predicted that Tracon Pharmaceuticals's share price could reach $60.00 by Apr 3, 2025. The average Tracon Pharmaceuticals stock price prediction forecasts a potential upside of 3,251.96% from the current TCON share price of $1.79.

What is TCON's forecast return on equity (ROE) for 2024-2027?

(NASDAQ: TCON) forecast ROE is N/A, which is considered weak.
©2024 WallStreetZen
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsHelp GuidesContactTwitterYouTubeNewsletter
Stock Tools
Top Performing AnalystsStock ScreenerStock ForecastTrending StocksStrong Buy StocksHighest Earnings StocksBest Dividend Paying StocksStatisticsStock Market SectorsStock Market IndustriesHow to Buy Stocks Online
Stock Ideas
Buy The DipBiggest Stock Gainers TodayBiggest Stock Losers Today52 Week High Stocks52 Week Low StocksMost Active Stocks TodayMost Undervalued StocksBest Penny Stocks to Buy NowBest Stocks Under $5Best Stocks Under $10
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.